SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : PFE (Pfizer) How high will it go?
PFE 25.73+2.2%11:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: BigKNY3 who wrote (4694)8/2/1998 8:31:00 PM
From: BigKNY3   of 9523
 
Big Pharma Report: 8/02/98

Have PFun!

Big KNY3

_________________________________________

- For the week, Big Pharma (-1.8%) followed the S&P down (-1.8%).

-GLX (+2.2%), JNJ (+0.9%), and LLY (+0.4%) were the only winners.

-PFE (-3.2%) continued its current bout of profit-taking on low-volume and no news.

-WLA (-5.6%) was the cellar-dweller on renewed concerns for Rezulin and liver complications.

-In July, Big Pharma was up 1.3% as compared to declines for the Dow (-0.8%), S&P (-1.2%) and the NASTie (-1.2%) .

-For the month, AMGEN (+12.3%), WLA (+8.6%), and SGP (5.6%) were the big winners. MRK (-7.6%), SBH (-5.0%), and BMY (-0.9%) were the only losers. PFE managed to increase 1.0% in roller coaster action.

-Through 7 months, Big Pharma (+28.5%) is far ahead of the Dow (+12.3%), S&P (+19.6%) and the NAStie (+19.2%).

-In the YTD race, the "Big 3" held their positions with #1 WLA (+82.1%) followed by SGP (+55.7%) and PFE (+47.3%). LLY (-3.4%) is the only Big Pharma in the red.

Have PFun!

BigKNY3
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext